Cite
Identification of patients at high risk of secondary extramedullary multiple myeloma development.
MLA
Stork, Martin, et al. “Identification of Patients at High Risk of Secondary Extramedullary Multiple Myeloma Development.” British Journal of Haematology, vol. 196, no. 4, Feb. 2022, pp. 954–62. EBSCOhost, https://doi.org/10.1111/bjh.17925.
APA
Stork, M., Sevcikova, S., Minarik, J., Krhovska, P., Radocha, J., Pospisilova, L., Brozova, L., Jarkovsky, J., Spicka, I., Straub, J., Pavlicek, P., Jungova, A., Jelinek, T., Sandecka, V., Maisnar, V., Hajek, R., & Pour, L. (2022). Identification of patients at high risk of secondary extramedullary multiple myeloma development. British Journal of Haematology, 196(4), 954–962. https://doi.org/10.1111/bjh.17925
Chicago
Stork, Martin, Sabina Sevcikova, Jiri Minarik, Petra Krhovska, Jakub Radocha, Lenka Pospisilova, Lucie Brozova, et al. 2022. “Identification of Patients at High Risk of Secondary Extramedullary Multiple Myeloma Development.” British Journal of Haematology 196 (4): 954–62. doi:10.1111/bjh.17925.